In vivo assessment of the toxic impact of exposure to magnetic iron oxide nanoparticles (IONPs) using Drosophila melanogaster

Copyright © 2024 Elsevier B.V. All rights reserved..

Iron oxide nanoparticles (IONPs) have useful properties, such as strong magnetism and compatibility with living organisms which is preferable for medical applications such as drug delivery and imaging. However, increasing use of these materials, especially in medicine, has raised concerns regarding potential risks to human health. In this study, IONPs were coated with silicon dioxide (SiO2), citric acid (CA), and polyethylenimine (PEI) to enhance their dispersion and biocompatibility. Both coated and uncoated IONPs were assessed for genotoxic effects on Drosophila melanogaster. Results showed that uncoated IONPs induced genotoxic effects, including mutations and recombinations, while the coated IONPs demonstrated reduced or negligible genotoxicity. Additionally, bioinformatic analyses highlighted potential implications of induced recombination in various cancer types, underscoring the importance of understanding nanoparticle-induced genomic instability. This study highlights the importance of nanoparticle coatings in reducing potential genotoxic effects and emphasizes the necessity for comprehensive toxicity assessments in nanomaterial research.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:107

Enthalten in:

Environmental toxicology and pharmacology - 107(2024) vom: 15. Apr., Seite 104412

Sprache:

Englisch

Beteiligte Personen:

Güneş, Merve [VerfasserIn]
Aktaş, Kemal [VerfasserIn]
Yalçın, Burçin [VerfasserIn]
Burgazlı, Ayşen Yağmur [VerfasserIn]
Asilturk, Meltem [VerfasserIn]
Ünşar, Ayca Erdem [VerfasserIn]
Kaya, Bülent [VerfasserIn]

Links:

Volltext

Themen:

7631-86-9
DNA damage
Ferric Compounds
Genotoxicity
Journal Article
Magnetic nanoparticles
Silicon Dioxide
Surface modification
Toxicity

Anmerkungen:

Date Completed 16.04.2024

Date Revised 16.04.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.etap.2024.104412

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM369824377